Earnings roundup

Several companies based in Utah or with ties to the state reported quarterly earnings Tuesday.

Intel Corp.

Strong demand for notebook computers powered by Intel Corp. chips helped boost third-quarter profits by 5 percent, but the technology bellwether missed analyst expectations by a penny.

In the three months ended Oct. 1, the world's largest maker of PC microprocessors earned $2 billion, or 32 cents per share, compared with $1.91 billion, or 30 cents a share, in the same period a year ago.

Revenue rose 18 percent to $9.96 billion compared with $8.47 billion in the year-ago period.

Intel has about 350 workers in Riverton.

Analysts were expecting the chip maker to earn $2.1 billion, or 33 cents per share, on sales of $9.92 billion, according to a survey by Thomson Financial.

Shares of Intel slid more than 3 percent in after-hours trading, falling 77 cents to $22.95, after gaining 26 cents during the regular Nasdaq session in advance of the earnings report.

Utah Medical Products

Salt Lake-based Utah Medical Products Inc. reported its sales were up 5 percent in the third quarter, gross profits up 6 percent, operating profits down 20 percent, net income down 1 percent and earnings per share up 13 percent, compared to the third quarter of 2004.

Kevin Cornwell, Utah Medical's chief executive officer, said operating profits were down substantially because of the company's legal expenses associated with a U.S. Food & Drug Administration lawsuit.

"The accrued liabilities reserve at the end of September reflects UTMD's latest estimate to complete the litigation process with the FDA," a company statement said. "Litigation expenses increased third quarter general and administrative expenses, which are part of operating expenses, by $710,000."

Net sales for the quarter were $7.0 million, up from $6.7 million compared to the same quarter in 2004.

Net income was at $1.79 million in the third quarter, down from $1.8 million in the third quarter of 2004. Earnings per share were at 44 cents, up from 39 cents.

Usana Health Sciences

Salt Lake-based Usana Health Sciences Inc. reported that its net sales grew 20 percent to $82.2 million for the third fiscal quarter ended Oct. 1, compared to $68.7 million during the same quarter last year.